Pub Date : 2024-06-04DOI: 10.12775/jehs.2024.73.51718
Karina Otręba, Karolina Czupryńska, Oliwia Czyżniewska, Mikołaj Domański, Barbara Kopczyńska, Julia Szałajska, Natalia Wierzejska, Maria Wojcieszek
Introduction Tension-type headaches (TTH) are a significant health concern that demands precise diagnostic approaches and effective management strategies. A nuanced understanding of their pathophysiology and diagnostic challenges is not just pivotal, but a responsibility we share, for enhancing patient care. Aim This article aims to explore the complex realm of TTH diagnosis and management, underlining the need for precision in diagnostics and the intricate balance of cost-effectiveness. It also delves into the diverse therapeutic options available for treating TTH, presenting a stimulating challenge for healthcare professionals, researchers, and medical students. State of Knowledge Initial diagnosis involves excluding secondary headaches by identifying red flags indicative of serious underlying conditions. A detailed medical history, complemented by patient-recorded pain diaries, enhances diagnostic accuracy. Ancillary procedures like neuroimaging, despite cost-effectiveness debates, are often preferred by clinicians to mitigate diagnostic risks. Validated tools such as the MIDAS and HIT-6 questionnaires provide valuable insights into headache-related disability. Differential diagnosis among headache types relies on recognizing distinctive clinical features. Summary (Conclusions) Effectively managing TTH necessitates a multifaceted approach, incorporating pharmacological, non-pharmacological, and lifestyle interventions tailored to individual patient needs. Collaborative efforts spanning legal, technological, and research domains are crucial for advancing headache diagnostics and therapeutics. While technological advancements offer promise, interdisciplinary collaboration remains fundamental in optimizing patient care outcomes.
{"title":"Precise Classification, and Accurate Diagnosis: Key Elements for Effective Treatment and Management of Headache Disorders","authors":"Karina Otręba, Karolina Czupryńska, Oliwia Czyżniewska, Mikołaj Domański, Barbara Kopczyńska, Julia Szałajska, Natalia Wierzejska, Maria Wojcieszek","doi":"10.12775/jehs.2024.73.51718","DOIUrl":"https://doi.org/10.12775/jehs.2024.73.51718","url":null,"abstract":"Introduction \u0000Tension-type headaches (TTH) are a significant health concern that demands precise diagnostic approaches and effective management strategies. A nuanced understanding of their pathophysiology and diagnostic challenges is not just pivotal, but a responsibility we share, for enhancing patient care. \u0000Aim \u0000 This article aims to explore the complex realm of TTH diagnosis and management, underlining the need for precision in diagnostics and the intricate balance of cost-effectiveness. It also delves into the diverse therapeutic options available for treating TTH, presenting a stimulating challenge for healthcare professionals, researchers, and medical students. \u0000State of Knowledge \u0000Initial diagnosis involves excluding secondary headaches by identifying red flags indicative of serious underlying conditions. A detailed medical history, complemented by patient-recorded pain diaries, enhances diagnostic accuracy. Ancillary procedures like neuroimaging, despite cost-effectiveness debates, are often preferred by clinicians to mitigate diagnostic risks. Validated tools such as the MIDAS and HIT-6 questionnaires provide valuable insights into headache-related disability. Differential diagnosis among headache types relies on recognizing distinctive clinical features. \u0000Summary (Conclusions) \u0000Effectively managing TTH necessitates a multifaceted approach, incorporating pharmacological, non-pharmacological, and lifestyle interventions tailored to individual patient needs. Collaborative efforts spanning legal, technological, and research domains are crucial for advancing headache diagnostics and therapeutics. While technological advancements offer promise, interdisciplinary collaboration remains fundamental in optimizing patient care outcomes.","PeriodicalId":15567,"journal":{"name":"Journal of Education, Health and Sport","volume":"5 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141265963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-04DOI: 10.12775/jehs.2024.73.51701
M. Czeczotka, Marta Skorupska, Natalia Aleksandra Popławska, Justyna Śliz, Krzysztof Woźniak
Introduction: This article reviews a number of studies that have sought to determine what are risk factors that may cause eating disorders in the pediatric population, taking into account the age and gender of the subjects. This study focuses on issues related to purging, bulimic behaviors, and psychological orthorexia and what impact the most common risk factors for these behaviors have in the pediatric population. Aim of study: The aim of the study is to present a comprehensive review of some of the most common risk factors predisposing to the development of eating disorders in the pediatric population, and how these factors have a direct impact on each other and are intertwined, by using available knowledge, paying particular attention to a new potential risk factor - social media. Materials and methods: Materials used in this study were found in the PubMed database, using the following keywords: ,,Social media”, ,,Mass media”, ,,Peers”, ,,Family”, ,,Orthorexia nervosa”, ,,Social media”, ,,Children”, ,,Adolescence”. Conclusion: Eating disorders are a growing problem. Our research focuses on potential risk factors, with the greatest emphasis on a relatively new risk factor: social media and screen time, and how these two factors influence young minds, what impact they have on the eating habits of children and adolescents, and what can be done to prevent eating disorders in the pediatric population.
{"title":"Eating disorders in pediatric population, analysis of some of the most common risk factors","authors":"M. Czeczotka, Marta Skorupska, Natalia Aleksandra Popławska, Justyna Śliz, Krzysztof Woźniak","doi":"10.12775/jehs.2024.73.51701","DOIUrl":"https://doi.org/10.12775/jehs.2024.73.51701","url":null,"abstract":"Introduction: \u0000This article reviews a number of studies that have sought to determine what are risk factors that may cause eating disorders in the pediatric population, taking into account the age and gender of the subjects. This study focuses on issues related to purging, bulimic behaviors, and psychological orthorexia and what impact the most common risk factors for these behaviors have in the pediatric population.\u0000 \u0000Aim of study:\u0000The aim of the study is to present a comprehensive review of some of the most common risk factors predisposing to the development of eating disorders in the pediatric population, and how these factors have a direct impact on each other and are intertwined, by using available knowledge, paying particular attention to a new potential risk factor - social media.\u0000 \u0000Materials and methods: \u0000Materials used in this study were found in the PubMed database, using the following keywords: ,,Social media”, ,,Mass media”, ,,Peers”, ,,Family”, ,,Orthorexia nervosa”, ,,Social media”, ,,Children”, ,,Adolescence”.\u0000 \u0000Conclusion: \u0000Eating disorders are a growing problem. Our research focuses on potential risk factors, with the greatest emphasis on a relatively new risk factor: social media and screen time, and how these two factors influence young minds, what impact they have on the eating habits of children and adolescents, and what can be done to prevent eating disorders in the pediatric population.","PeriodicalId":15567,"journal":{"name":"Journal of Education, Health and Sport","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141266729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-04DOI: 10.12775/jehs.2024.61.51833
Norbert Gruszczyński, Radosław Perkowski
Introduction: Falls of the elderly are a significant problem for public health and healthcare. They are also included in the geriatric giants, and the assessment of balance and risk of falls is an important part of the comprehensive geriatric assessment (CGA). It is estimated that almost one in three people over the age of 65 living independently in a community suffers one fall per year. These estimates increase with age, and in people older than 80 years, every second senior may experience at least one fall. The aim of the study was to assess the balance and risk of falls in people over 60 years of age living independently in society. Materials and methods: The study enrolled 40 seniors over the age of 60 who agreed to participate in the study and met the inclusion criteria. Three functional tests were used to assess balance and the risk of falls among seniors: the Timed Up and Go (TUG), the Four Square Step Test (FSST) and One-leg standing (OLS). Result: The study shows that as age increases, subjects perform worse on the Timed Up and Go rho = 0.38 test; p < 0.05 and in the Four Square Step Test rho = 0.53; p < 0.01. No statistically significant differences were observed between genders or age groups in the One Leg Standing test (OLS), although older people scored worse than younger age groups. There were no statistically significant associations between performance test results and BMI. The average results of the clinical tests show that the seniors in the study had good balance and a low risk of falling.
{"title":"Assessment of balance and risk of falls in people over 60 years old","authors":"Norbert Gruszczyński, Radosław Perkowski","doi":"10.12775/jehs.2024.61.51833","DOIUrl":"https://doi.org/10.12775/jehs.2024.61.51833","url":null,"abstract":"Introduction: Falls of the elderly are a significant problem for public health and healthcare. They are also included in the geriatric giants, and the assessment of balance and risk of falls is an important part of the comprehensive geriatric assessment (CGA). It is estimated that almost one in three people over the age of 65 living independently in a community suffers one fall per year. These estimates increase with age, and in people older than 80 years, every second senior may experience at least one fall. The aim of the study was to assess the balance and risk of falls in people over 60 years of age living independently in society. Materials and methods: The study enrolled 40 seniors over the age of 60 who agreed to participate in the study and met the inclusion criteria. Three functional tests were used to assess balance and the risk of falls among seniors: the Timed Up and Go (TUG), the Four Square Step Test (FSST) and One-leg standing (OLS). Result: The study shows that as age increases, subjects perform worse on the Timed Up and Go rho = 0.38 test; p < 0.05 and in the Four Square Step Test rho = 0.53; p < 0.01. No statistically significant differences were observed between genders or age groups in the One Leg Standing test (OLS), although older people scored worse than younger age groups. There were no statistically significant associations between performance test results and BMI. The average results of the clinical tests show that the seniors in the study had good balance and a low risk of falling.","PeriodicalId":15567,"journal":{"name":"Journal of Education, Health and Sport","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141266867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-04DOI: 10.12775/jehs.2024.73.51699
Rafal Makuch, Alicja Chrościcka, Kamil Gała, Andrzej Czajka, Paweł Lenard, Adam Kucharski, Sara Michalska, Konrad Pilarski, Martyna Dewicka, Alicja Maria Wawrzyniak
Introduction and objective: Diabetes represents one of the most significant healthcare challenges of the 21st century. The disease is frequently asymptomatic, with patients often remaining undiagnosed for extended periods and failing to seek assistance from healthcare professionals. A sedentary lifestyle, excessive caloric intake, and a lack of physical activity contribute to the development of obesity, which in turn leads to carbohydrate metabolism disorders. In this study, we will examine the relationship between diabetes and obesity, and discuss the drug semaglutide, which is used to treat type 2 diabetes and also promotes weight loss. Review methods: Review and summary of research studies available in open-source format on Google Scholar, PubMed. Abbreviated description of the state of knowledge: Numerous clinical studies have demonstrated the efficacy of semaglutide in improving lipid profiles and promoting weight loss. This effect is believed to be mediated by the drug's ability to slow gastric emptying. It is evident that semaglutide, a glucagon-like peptide-1 (GLP-1) analogue, exerts a beneficial effect on carbohydrate parameters and helps to delay the occurrence of complications associated with diabetes. Summary: A review of clinical reports and conducted studies indicates that semaglutide has the potential to enhance parameters that directly or indirectly impact the quality of life of patients with diabetes. However, the utilisation of the aforementioned pharmaceutical is associated with adverse effects, which may impede patient-physician collaboration and potentially precipitate the development of new health complications in patients. One of the effects of semaglutide treatment is a reduction in appetite, which contributes to weight loss. This property of the drug makes it suitable for use in patients with excessive body weight.
{"title":"Semaglutide in the Treatment of Diabetes and Associated Obesity","authors":"Rafal Makuch, Alicja Chrościcka, Kamil Gała, Andrzej Czajka, Paweł Lenard, Adam Kucharski, Sara Michalska, Konrad Pilarski, Martyna Dewicka, Alicja Maria Wawrzyniak","doi":"10.12775/jehs.2024.73.51699","DOIUrl":"https://doi.org/10.12775/jehs.2024.73.51699","url":null,"abstract":"Introduction and objective: Diabetes represents one of the most significant healthcare challenges of the 21st century. The disease is frequently asymptomatic, with patients often remaining undiagnosed for extended periods and failing to seek assistance from healthcare professionals. A sedentary lifestyle, excessive caloric intake, and a lack of physical activity contribute to the development of obesity, which in turn leads to carbohydrate metabolism disorders. In this study, we will examine the relationship between diabetes and obesity, and discuss the drug semaglutide, which is used to treat type 2 diabetes and also promotes weight loss. \u0000Review methods: Review and summary of research studies available in open-source format on Google Scholar, PubMed. \u0000Abbreviated description of the state of knowledge: Numerous clinical studies have demonstrated the efficacy of semaglutide in improving lipid profiles and promoting weight loss. This effect is believed to be mediated by the drug's ability to slow gastric emptying. It is evident that semaglutide, a glucagon-like peptide-1 (GLP-1) analogue, exerts a beneficial effect on carbohydrate parameters and helps to delay the occurrence of complications associated with diabetes. \u0000Summary: A review of clinical reports and conducted studies indicates that semaglutide has the potential to enhance parameters that directly or indirectly impact the quality of life of patients with diabetes. However, the utilisation of the aforementioned pharmaceutical is associated with adverse effects, which may impede patient-physician collaboration and potentially precipitate the development of new health complications in patients. One of the effects of semaglutide treatment is a reduction in appetite, which contributes to weight loss. This property of the drug makes it suitable for use in patients with excessive body weight.","PeriodicalId":15567,"journal":{"name":"Journal of Education, Health and Sport","volume":"7 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141267722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-04DOI: 10.12775/jehs.2024.61.51834
Jakub Ciesielski, Radosław Perkowski
Introduction: An ageing of population is becoming more and more common. With age, the functionality and efficiency of the body decreases. As a result, the time spent by seniors on physical activity is shortened and physical fitness decreases. For this reason, the physical fitness of seniors should be regularly checked and they should be encouraged to take up physical activity. There are many proven and reliable tests used to assess physical fitness. Materials and methods: The study group consisted of 40 people (31 women and 9 men), aged 60-78 years. The tests used in following study were: the SPPB questionnaire, handgrip strength test, and arm and calf circumference measurements. An attempt was made to find sociodemographic factors that could influence the level of physical fitness. It was checked whether physical fitness and physical activity depend on age, gender and BMI. It was checked how much time older people spend on physical activity during the day and week. The study confirmed that physical fitness decreases with age. Results: Tests and interviews have shown that people who spend more than 60 minutes a day on physical activity achieve higher scores on the SPPB questionnaire. These results were applicable to both women and men. Studies in a larger and more diverse population would need to be repeated in order to further confirm these results and draw more conclusions.
{"title":"Assessment of physical fitness among people over 60 years of age","authors":"Jakub Ciesielski, Radosław Perkowski","doi":"10.12775/jehs.2024.61.51834","DOIUrl":"https://doi.org/10.12775/jehs.2024.61.51834","url":null,"abstract":"Introduction: An ageing of population is becoming more and more common. With age, the functionality and efficiency of the body decreases. As a result, the time spent by seniors on physical activity is shortened and physical fitness decreases. For this reason, the physical fitness of seniors should be regularly checked and they should be encouraged to take up physical activity. There are many proven and reliable tests used to assess physical fitness. Materials and methods: The study group consisted of 40 people (31 women and 9 men), aged 60-78 years. The tests used in following study were: the SPPB questionnaire, handgrip strength test, and arm and calf circumference measurements. An attempt was made to find sociodemographic factors that could influence the level of physical fitness. It was checked whether physical fitness and physical activity depend on age, gender and BMI. It was checked how much time older people spend on physical activity during the day and week. The study confirmed that physical fitness decreases with age. Results: Tests and interviews have shown that people who spend more than 60 minutes a day on physical activity achieve higher scores on the SPPB questionnaire. These results were applicable to both women and men. Studies in a larger and more diverse population would need to be repeated in order to further confirm these results and draw more conclusions.","PeriodicalId":15567,"journal":{"name":"Journal of Education, Health and Sport","volume":"82 21","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141268366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-03DOI: 10.12775/jehs.2024.73.51686
Marta Skorupska, M. Czeczotka, Martyna Magdalena Martka, Natalia Aleksandra Popławska, Justyna Śliz, Krzysztof Woźniak
Introduction: JAK inhibitors are used in the treatment of psoriatic arthritis when there is a lack of effective response or intolerance to first-line drugs or their use must be discontinued due to the presence of side effects. JAK inhibitors inhibit the JAK-STAT signaling pathway which plays a significant role in the pathogenesis of many inflammatory and autoimmune diseases. This mechanism leads to a reduction in the level of pro-inflammatory cytokines which causes rapid improvement in the patient's clinical condition. Tofacitinib is the best-known drug in this group; its use carries an increased risk of cardiovascular events and reactivation of the varicella-zoster virus. Regular monitoring of patients results in faster detection of the first signs of undesirable effects and the cessation of their progression. The drug's safety profile is acceptable and the benefits outweigh possible complications. Aim of the study: The aim of the study is to summarize the available knowledge about tofacitinib treatment in psoriatic arthritis. The way of work, effectiveness of treatment and potential side effects were summarized and described. Materials and methods: The literature available in PubMed database was reviewed using the following keywords: “Psoriatic arthritis”, “Tofacitinib”, “JAK inhibitors”, “JAK-STAT” Conclusion: Tofacitinib treatment in rheumatology is used in psoriatic arthritis. The rapid improvement in the clinical condition of patients treated with JAK inhibitors is due to their direct impact on the modulation of the pathogenesis of the disease. The predictable benefits of therapy outweigh the side effects which can be detected at an early stage with regular monitoring of the patient.
导读：JAK抑制剂用于治疗银屑病关节炎，当一线药物疗效不佳或不耐受，或因出现副作用而必须停止使用时，就会使用JAK抑制剂。JAK 抑制剂可抑制 JAK-STAT 信号通路，该通路在许多炎症和自身免疫性疾病的发病机制中发挥着重要作用。这种机制可降低促炎细胞因子的水平，从而迅速改善患者的临床状况。托法替尼是这类药物中最著名的一种；使用这种药物会增加心血管事件和水痘-带状疱疹病毒再激活的风险。对患者进行定期监测可以更快地发现不良反应的最初迹象并阻止其发展。该药物的安全性是可以接受的，其益处大于可能出现的并发症。研究目的本研究旨在总结有关托法替尼治疗银屑病关节炎的现有知识。总结并描述了工作方式、治疗效果和潜在副作用。材料与方法：使用以下关键词查阅了PubMed数据库中的文献："银屑病关节炎"、"托法替尼"、"JAK抑制剂"、"JAK-STAT" 结论：风湿病学中的托法替尼治疗用于银屑病关节炎。接受 JAK 抑制剂治疗的患者的临床状况之所以能迅速改善，是因为这些抑制剂对疾病发病机制的调节产生了直接影响。可预见的治疗效果大于副作用，而副作用可以通过对患者的定期监测在早期发现。
{"title":"Psoriatic arthritis - Tofacitinib as a new treatment","authors":"Marta Skorupska, M. Czeczotka, Martyna Magdalena Martka, Natalia Aleksandra Popławska, Justyna Śliz, Krzysztof Woźniak","doi":"10.12775/jehs.2024.73.51686","DOIUrl":"https://doi.org/10.12775/jehs.2024.73.51686","url":null,"abstract":"Introduction:\u0000JAK inhibitors are used in the treatment of psoriatic arthritis when there is a lack of effective response or intolerance to first-line drugs or their use must be discontinued due to the presence of side effects. JAK inhibitors inhibit the JAK-STAT signaling pathway which plays a significant role in the pathogenesis of many inflammatory and autoimmune diseases. This mechanism leads to a reduction in the level of pro-inflammatory cytokines which causes rapid improvement in the patient's clinical condition. Tofacitinib is the best-known drug in this group; its use carries an increased risk of cardiovascular events and reactivation of the varicella-zoster virus. Regular monitoring of patients results in faster detection of the first signs of undesirable effects and the cessation of their progression. The drug's safety profile is acceptable and the benefits outweigh possible complications.\u0000 \u0000Aim of the study:\u0000 \u0000The aim of the study is to summarize the available knowledge about tofacitinib treatment in psoriatic arthritis. The way of work, effectiveness of treatment and potential side effects were summarized and described.\u0000 \u0000Materials and methods:\u0000 \u0000The literature available in PubMed database was reviewed using the following keywords:\u0000“Psoriatic arthritis”, “Tofacitinib”, “JAK inhibitors”, “JAK-STAT”\u0000 \u0000Conclusion:\u0000 \u0000Tofacitinib treatment in rheumatology is used in psoriatic arthritis. The rapid improvement in the clinical condition of patients treated with JAK inhibitors is due to their direct impact on the modulation of the pathogenesis of the disease. The predictable benefits of therapy outweigh the side effects which can be detected at an early stage with regular monitoring of the patient.","PeriodicalId":15567,"journal":{"name":"Journal of Education, Health and Sport","volume":"3 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141271754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-03DOI: 10.12775/jehs.2024.73.51697
Patrycja Dębiec, Jakub Roman, Daniel Gondko, Nikodem Pietrzak
Introduction and Purpose: Accurate diagnosis of Lyme disease remains challenging due to its varied manifestations and the limitations of current diagnostic tests. This review examines the emerging role of artificial intelligence (AI) in enhancing the diagnostic accuracy for Lyme disease, aiming to understand how these technologies can be integrated into clinical practice.State of Knowledge: AI and machine learning techniques are increasingly applied to improve diagnostic processes. In Lyme disease, AI models have been developed to identify patterns in clinical data, enhancing early detection and accuracy. Studies have focused on using AI to interpret complex serological results and clinical symptoms more effectively than traditional methods. Additionally, AI has been utilized to analyze geographical and epidemiological data to predict Lyme disease risk areas, aiding in preventive strategies.Summary: AI holds significant promise in transforming Lyme disease diagnostics by increasing the speed and accuracy of detection. These technologies not only help in overcoming the limitations of current serological testing but also provide a framework for predictive analytics in epidemiology. As AI models continue to evolve, their integration into healthcare systems requires careful consideration of ethical implications and validation on broader scales. Future research should focus on refining AI algorithms, improving data inclusivity, and enhancing interoperability with existing medical systems to fully realize AI's potential in battling Lyme disease.
{"title":"AI and Lyme Disease: Pioneering Advances in Diagnostic Accuracy","authors":"Patrycja Dębiec, Jakub Roman, Daniel Gondko, Nikodem Pietrzak","doi":"10.12775/jehs.2024.73.51697","DOIUrl":"https://doi.org/10.12775/jehs.2024.73.51697","url":null,"abstract":"Introduction and Purpose: Accurate diagnosis of Lyme disease remains challenging due to its varied manifestations and the limitations of current diagnostic tests. This review examines the emerging role of artificial intelligence (AI) in enhancing the diagnostic accuracy for Lyme disease, aiming to understand how these technologies can be integrated into clinical practice.State of Knowledge: AI and machine learning techniques are increasingly applied to improve diagnostic processes. In Lyme disease, AI models have been developed to identify patterns in clinical data, enhancing early detection and accuracy. Studies have focused on using AI to interpret complex serological results and clinical symptoms more effectively than traditional methods. Additionally, AI has been utilized to analyze geographical and epidemiological data to predict Lyme disease risk areas, aiding in preventive strategies.Summary: AI holds significant promise in transforming Lyme disease diagnostics by increasing the speed and accuracy of detection. These technologies not only help in overcoming the limitations of current serological testing but also provide a framework for predictive analytics in epidemiology. As AI models continue to evolve, their integration into healthcare systems requires careful consideration of ethical implications and validation on broader scales. Future research should focus on refining AI algorithms, improving data inclusivity, and enhancing interoperability with existing medical systems to fully realize AI's potential in battling Lyme disease.","PeriodicalId":15567,"journal":{"name":"Journal of Education, Health and Sport","volume":"110 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141272169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-03DOI: 10.12775/jehs.2024.73.51693
Patrycja Dębiec, Jakub Roman, Daniel Gondko, Nikodem Pietrzak
Introduction and Purpose: Phototherapy, involving the therapeutic use of ultraviolet and visible light, has been a cornerstone in dermatology for treating various skin disorders. This review aims to consolidate current knowledge on the mechanisms of action and clinical applications of phototherapy, with a focus on enhancing understanding among clinicians and researchers.State of Knowledge: Phototherapy is particularly effective for chronic conditions such as psoriasis, vitiligo, and atopic dermatitis, where traditional therapies might not suffice. The mechanism involves modulation of immune response and inhibition of cellular proliferation, achieved through various wavelengths, including UVA and UVB. Recent advancements have introduced narrow-band UVB, which offers targeted therapy with fewer side effects compared to broad-band UVB. Moreover, the review explores innovations such as LED-based therapies and photodynamic therapy, expanding the spectrum of phototherapeutic options.Summary: Phototherapy remains a vital and evolving treatment modality in dermatology, offering safe and effective management for multiple skin disorders. Its success hinges on precise application and adherence to treatment protocols. Future research should aim to optimize treatment regimens, reduce side effects, and enhance patient compliance to improve outcomes. By advancing our understanding and application of phototherapy, we can better tailor treatments to meet individual patient needs, thereby improving the quality of life for those afflicted with chronic skin conditions.
简介和目的：光疗涉及紫外线和可见光的治疗使用，一直是皮肤病学治疗各种皮肤疾病的基石。这篇综述旨在整合当前有关光疗作用机制和临床应用的知识，重点是加深临床医生和研究人员对光疗的理解：光疗对牛皮癣、白癜风和特应性皮炎等传统疗法无法根治的慢性疾病尤为有效。其机理包括通过各种波长（包括 UVA 和 UVB）调节免疫反应和抑制细胞增殖。与宽波段紫外线相比，窄波段紫外线具有针对性强、副作用小的特点。此外，该综述还探讨了基于 LED 的疗法和光动力疗法等创新，从而扩大了光疗选择的范围。摘要：光疗仍然是皮肤科中一种重要且不断发展的治疗方式，可安全有效地治疗多种皮肤疾病。其成功与否取决于精确的应用和治疗方案的坚持。未来的研究应致力于优化治疗方案，减少副作用，提高患者的依从性，以改善治疗效果。通过提高我们对光疗的认识和应用，我们可以更好地定制治疗方案，满足患者的个性化需求，从而提高慢性皮肤病患者的生活质量。
{"title":"Clinical Applications of Phototherapy in Treating Skin Disorders","authors":"Patrycja Dębiec, Jakub Roman, Daniel Gondko, Nikodem Pietrzak","doi":"10.12775/jehs.2024.73.51693","DOIUrl":"https://doi.org/10.12775/jehs.2024.73.51693","url":null,"abstract":"Introduction and Purpose: Phototherapy, involving the therapeutic use of ultraviolet and visible light, has been a cornerstone in dermatology for treating various skin disorders. This review aims to consolidate current knowledge on the mechanisms of action and clinical applications of phototherapy, with a focus on enhancing understanding among clinicians and researchers.State of Knowledge: Phototherapy is particularly effective for chronic conditions such as psoriasis, vitiligo, and atopic dermatitis, where traditional therapies might not suffice. The mechanism involves modulation of immune response and inhibition of cellular proliferation, achieved through various wavelengths, including UVA and UVB. Recent advancements have introduced narrow-band UVB, which offers targeted therapy with fewer side effects compared to broad-band UVB. Moreover, the review explores innovations such as LED-based therapies and photodynamic therapy, expanding the spectrum of phototherapeutic options.Summary: Phototherapy remains a vital and evolving treatment modality in dermatology, offering safe and effective management for multiple skin disorders. Its success hinges on precise application and adherence to treatment protocols. Future research should aim to optimize treatment regimens, reduce side effects, and enhance patient compliance to improve outcomes. By advancing our understanding and application of phototherapy, we can better tailor treatments to meet individual patient needs, thereby improving the quality of life for those afflicted with chronic skin conditions.","PeriodicalId":15567,"journal":{"name":"Journal of Education, Health and Sport","volume":"3 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141272714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-03DOI: 10.12775/jehs.2024.73.51692
Daniel Gondko, Patrycja Dębiec, Jakub Roman, Nikodem Pietrzak
Introduction and Purpose: Long-distance running, especially marathons, tests human endurance and physical limits. While the benefits of marathon running are well-documented, the associated health risks often go unnoticed. This review aims to synthesize current knowledge on the health risks and complications faced by marathon runners, providing crucial insights for both amateur and professional athletes.State of Knowledge: Marathon running imposes significant stress on the cardiovascular system, musculoskeletal structure, and metabolic processes. Issues such as acute myocardial injury, overhydration leading to hyponatremia, and musculoskeletal injuries are prevalent. The review also examines less common but severe risks like rhabdomyolysis and marathon-related cardiac arrests. Despite the robust fitness levels of runners, these health risks remain a serious concern, necessitating preventive strategies and proper health monitoring.Summary: Marathon runners must be aware of the potential health risks associated with prolonged endurance activities. Precautionary measures, including tailored training programs, dietary adjustments, and regular medical check-ups, are essential to mitigate these risks. Additionally, further research is required to develop more effective interventions and guidelines that can safeguard the health of marathon participants. This review underscores the need for a balanced approach that respects the physiological demands of marathon running while ensuring the health and safety of the runners.
{"title":"Marathon Health Pitfalls: What Every Runner Needs to Know","authors":"Daniel Gondko, Patrycja Dębiec, Jakub Roman, Nikodem Pietrzak","doi":"10.12775/jehs.2024.73.51692","DOIUrl":"https://doi.org/10.12775/jehs.2024.73.51692","url":null,"abstract":"Introduction and Purpose: Long-distance running, especially marathons, tests human endurance and physical limits. While the benefits of marathon running are well-documented, the associated health risks often go unnoticed. This review aims to synthesize current knowledge on the health risks and complications faced by marathon runners, providing crucial insights for both amateur and professional athletes.State of Knowledge: Marathon running imposes significant stress on the cardiovascular system, musculoskeletal structure, and metabolic processes. Issues such as acute myocardial injury, overhydration leading to hyponatremia, and musculoskeletal injuries are prevalent. The review also examines less common but severe risks like rhabdomyolysis and marathon-related cardiac arrests. Despite the robust fitness levels of runners, these health risks remain a serious concern, necessitating preventive strategies and proper health monitoring.Summary: Marathon runners must be aware of the potential health risks associated with prolonged endurance activities. Precautionary measures, including tailored training programs, dietary adjustments, and regular medical check-ups, are essential to mitigate these risks. Additionally, further research is required to develop more effective interventions and guidelines that can safeguard the health of marathon participants. This review underscores the need for a balanced approach that respects the physiological demands of marathon running while ensuring the health and safety of the runners.","PeriodicalId":15567,"journal":{"name":"Journal of Education, Health and Sport","volume":"48 27","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141269854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-03DOI: 10.12775/jehs.2024.73.51712
Kamil Walczak, Julia Krasnoborska, Sylwia Samojedny, Maciej Superson, Katarzyna Szmyt, Katarzyna Szymańska, Klaudia Wilk-Trytko
Background: Creatine, a naturally occurring compound plays a crucial role in cellular energy metabolism, particularly in tissues with high energy demands like muscles and the brain. Beyond its well-established role in physical performance enhancement, recent research has revealed its potential benefits for cognitive functions and mood regulation. This review paper aims to comprehensively analyze the existing literature on creatine supplementation's effects on cognitive functions and mood. State of Knowledge: Findings suggest that creatine supplementation enhances memory, attention, and executive functions, especially under conditions of stress or sleep deprivation. Moreover, it exhibits mood-stabilizing effects, potentially offering relief for symptoms of depression and fatigue. Creatine's ability to augment brain energy metabolism, alongside its neuroprotective properties, underlies its cognitive and mood-enhancing effects. While generally safe, caution is advised, particularly in populations with kidney diseases or those using medications affecting kidney function. Summary: Creatine emerges as a promising adjunct therapy for enhancing cognitive functions and promoting emotional well-being beyond its traditional role in physical performance.The review underscores the need for further research to elucidate the precise mechanisms of creatine's effects and explore its synergistic potential with other cognitive-enhancing supplements.
{"title":"Effect of creatine supplementation on cognitive function and mood","authors":"Kamil Walczak, Julia Krasnoborska, Sylwia Samojedny, Maciej Superson, Katarzyna Szmyt, Katarzyna Szymańska, Klaudia Wilk-Trytko","doi":"10.12775/jehs.2024.73.51712","DOIUrl":"https://doi.org/10.12775/jehs.2024.73.51712","url":null,"abstract":"Background: Creatine, a naturally occurring compound plays a crucial role in cellular energy metabolism, particularly in tissues with high energy demands like muscles and the brain. Beyond its well-established role in physical performance enhancement, recent research has revealed its potential benefits for cognitive functions and mood regulation. This review paper aims to comprehensively analyze the existing literature on creatine supplementation's effects on cognitive functions and mood. \u0000State of Knowledge: Findings suggest that creatine supplementation enhances memory, attention, and executive functions, especially under conditions of stress or sleep deprivation. Moreover, it exhibits mood-stabilizing effects, potentially offering relief for symptoms of depression and fatigue. Creatine's ability to augment brain energy metabolism, alongside its neuroprotective properties, underlies its cognitive and mood-enhancing effects. While generally safe, caution is advised, particularly in populations with kidney diseases or those using medications affecting kidney function. \u0000Summary: Creatine emerges as a promising adjunct therapy for enhancing cognitive functions and promoting emotional well-being beyond its traditional role in physical performance.The review underscores the need for further research to elucidate the precise mechanisms of creatine's effects and explore its synergistic potential with other cognitive-enhancing supplements. \u0000 ","PeriodicalId":15567,"journal":{"name":"Journal of Education, Health and Sport","volume":"32 13","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141270844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：